Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression.
Winkler CA, Hendel H, Carrington M, Smith MW, Nelson GW, O'brien SJ, Phair J, Vlahov D, Jacobson LP, Rappaport J, Vasilescu A, Bertin-Maghit S, An P, Lu W, Andrieu JM, Schächter F, Therwath A, Zagury JF.
Winkler CA, et al. Among authors: vlahov d.
J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1534-8. doi: 10.1097/01.qai.0000127353.01578.63.
J Acquir Immune Defic Syndr. 2004.
PMID: 15602133